
businessAug 27, 20264:09pending
EnWave unveils efficiency plan targeting profitability, $1M annual cost savings
About this episode
EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to discuss a new operational efficiency plan designed to improve profitability, strengthen cash flow generation, and sharpen the company’s focus on its highest-margin growth opportunities.
The plan centers on the strategic wind-down of EnWave’s REVworx™ co-manufacturing operations, reflecting the increasing commercial maturity and adoption of the company’s proprietary Radiant Energy Vacuum (REV™) dehydration technology. Management believes the move will streamline operations while reinforcing EnWave’s transition toward a higher-margin business model built around equipment sales and recurring royalty revenue.
Charleton explained that REVworx™ was originally created to help customers accelerate commercialization of REV™-dried products by providing access to commercial-scale manufacturing capacity. However, as EnWave’s global network of licensed partners has expanded, those partners now provide sufficient production capacity for new customers evaluating REV™ technology, reducing the need for EnWave to maintain its own dedicated co-manufacturing facility.
As a result, the company expects the restructuring to generate approximately $1 million in annual operating cost savings by fiscal 2028 through lower facility expenses, labour costs, and other operating expenditures. EnWave projects that these savings will begin to materialize throughout fiscal 2027 and contribute at least $1 million in additional annual net income once fully implemented.
The initiative is also expected to unlock additional value through the potential sale of equipment currently dedicated to REVworx™, including a 10kW and a 60kW REV™ machine. The company estimates these assets have a combined resale value of approximately $2 million, creating an opportunity for both monetization and future machine sales to customers.
Once the restructuring is complete, EnWave expects its annual operating expense base to decline to roughly $3.7 million, significantly improving operating leverage and positioning the business for sustainable profitability. Management also believes annualized base royalty revenue could reach approximately $3 million by the end of fiscal 2027, largely covering the company’s pro forma operating costs.
Charleton also noted that the company’s commercial pipeline remains strong, with multiple large food companies evaluating REV™ as an alternative to traditional dehydration technologies. Recent customer activity, including the purchase of a second 120kW REV™ machine by Procescir, highlights the scalability of the technology and the potential for existing partners to expand production capacity over time.
#proactiveinvestors #enwavecorporation #tsxv #enw #REVTechnology #FoodTech #OperationalEfficiency #Profitability #RoyaltyRevenue #FoodInnovation #Manufacturing #DehydrationTechnology #InvestingNews
Get every episode summarized
Each time Proactive - Interviews for investors publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Proactive - Interviews for investors

Titan Minerals extends gold-silver mineralisation at Dynasty
Proactive - Interviews for investors
Sep 9, 20263:46failed

Krakatoa Resources: Zopkhito drilling extends gold-antimony potential
Proactive - Interviews for investors
Sep 9, 20264:07failed

Gaming Realms CEO: Content growth accelerating as company expands into new marke...
Proactive - Interviews for investors
Sep 9, 20262:59failed

genedrive CEO: NHS adoption and global expansion drive point-of-care testing pus...
Proactive - Interviews for investors
Sep 9, 20268:49failed